CHRNA7 and serum lipopolysaccharide activity: For instance, Terrando et al. demonstrated that the α7 nAChR agonist PHA 568487 (0.4 mg/kg i.p.)had anti-neuroinflammatory properties in a model of tibia fracture and endotoxemia when injected 2 h post-insult [48].